entertainment -WSS

entertainment

author：focus 2025-08-10 11:41:37 - browse：9991

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

hotspot

WSS

Alabama frozen embryo ruling has major implications for IVF clinics

STAT readers on older presidents, polypills, Medicare, and more

At ASCO, AstraZeneca reports strong data for breast cancer drug

Letters to First Opinion on caregivers, digital health, and more

NIH documents show early flaws of $1.6 billion long Covid program

Change Healthcare can notify patients about the breach, HHS says

focus

entertainment

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

NIH study of ME/CFS points to clear biological hallmarks

At least 13 dead in Texas as scorching temps continue

See how much Covid

Medicare details structure of new drug price negotiation program

R1 RCM gets $5.8 billion buyout offer from private equity firm

United colonoscopy coverage change 'may cost lives,' doctors say

How to increase colonoscopy rates? Looks like an AI can help

BioMarin wins approval for gene therapy to treat hemophilia A

STAT readers on older presidents, polypills, Medicare, and more

explore

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Letters to First Opinion on caregivers, digital health, and more

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

entertainment

leisure time

hotspot

Wikipedia